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endothelial selectin and thrombomodulin, using Z-scores, 
into a biomarker score and (2) by flow-mediated vasodi-
lation (FMD), and low-grade inflammation by combining 
C-reactive protein, serum amyloid A, interleukin 6, inter-
leukin 8, tumour necrosis factor α and sICAM-1 into a bio-
marker score, with smaller FMD and higher scores repre-
senting more dysfunction and inflammation, respectively. 
We used linear regression analyses to adjust associations 
for sex, age, energy, glucose metabolism, body mass index, 
smoking, prior CVD, educational level, physical activity 
and each of the other food groups.
Results  Moderate [β (95% CI) −0.13 (−0.33; 0.07)] and 
high [−0.22 (−0.45; −0.003)] alcohol consumption, and red 
wine [−0.16 (−0.30; −0.01)] consumption, but none of the 
other food groups, were associated with a lower endothe-
lial dysfunction biomarker score and a greater FMD. The 
associations for FMD were, however, not statistically sig-
nificant. Only red wine consumption was associated with 
Abstract 
Purpose Endothelial dysfunction and low-grade inflam-
mation are key phenomena in the pathobiology of cardio-
vascular disease (CVD). Their dietary modification might 
explain the observed reduction in CVD that has been 
associated with a healthy diet rich in fruit, vegetables and 
fish, low in dairy products and with moderate alcohol and 
red wine consumption. We investigated the associations 
between the above food groups and endothelial dysfunction 
and low-grade inflammation in a population-based cohort 
of Dutch elderly individuals.
Methods  Diet was measured by food frequency ques-
tionnaire (n = 801; women = 399; age 68.5 ± 7.2 years). 
Endothelial dysfunction was determined (1) by combining 
von Willebrand factor, and soluble intercellular adhesion 
molecule 1 (sICAM-1), vascular cell adhesion molecule 1, 
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a lower low-grade inflammation biomarker score [−0.18 
(−0.33; −0.04)].
Conclusions Alcohol and red wine consump-
tion may favourably influence processes involved in 
atherothrombosis.
Keywords Diet · Endothelial dysfunction · 
Inflammation · Elderly · Red wine
Introduction
A healthy diet, rich in fruit, vegetables and fish, low in 
dairy products and with moderate alcohol and red wine 
consumption, is associated with a reduced incidence of car-
diovascular disease (CVD) [1]. Endothelial dysfunction and 
low-grade inflammation are key phenomena in the patho-
biology of CVD [2] and seem to be influenced by dietary 
intake to the extent that a healthy diet is associated with 
less endothelial dysfunction and less low-grade inflam-
mation [3–5]. A healthy diet, therefore, could potentially 
reduce the incidence of CVD by acting favourably upon 
both endothelial dysfunction and low-grade inflammation.
Several of the previous population-based studies on the 
association between diet and biomarkers of endothelial 
dysfunction and biomarkers of low-grade inflammation 
focused on diet scores that included fish, fruit, vegetables, 
dairy products, and alcohol and red wine, whereas others 
investigated some of these food components separately 
[3–8]. None of the previous studies, however, examined 
each of these food components of a healthy diet in relation 
to each other [9]. Notably, population-based data on the 
association between diet and flow-mediated vasodilation 
(FMD) of the brachial artery, an estimate of endothelium-
dependent vasodilator function, are scarce [10, 11].
The consumption of red wine has been shown to act 
favourably upon endothelial dysfunction and low-grade 
inflammation [12]. It remains, however, unclear to what 
extent alcohol itself (i.e. ethanol) or any additional nutrient 
components such as polyphenols and flavonoids determine 
the association between red wine and endothelial dysfunc-
tion and low-grade inflammation [13].
We therefore examined, in order to investigate in detail 
the associations between a healthy diet and endothelial 
dysfunction and low-grade inflammation, the associations 
between, on the one hand, fruit, vegetables, fish, dairy 
products, alcohol and red wine consumption and, on the 
other, five biomarkers of endothelial dysfunction and FMD, 
and six biomarkers of low-grade inflammation. In addition, 
we investigated whether any such associations were inde-
pendent of each of the other food components of a healthy 
diet and lifestyle risk factors. Although the results will 
focus on any independent associations, we systematically 
report on each of these food groups in a large population-
based cohort study of elderly individuals.
Methods
Study population
For the present study, data were used from the 2000 Hoorn 
Study follow-up examination, previously described else-
where [14–16]. Of the original 822 participants, 20 were 
without dietary and biomarker data and one was without 
all covariate data (by participating only partially in the first 
study visit only) [14]. Of the remaining 801 participants, 
63 were without biomarker data [16] and 158 were without 
FMD data [15]. Thus, for the present analyses full data on 
diet and biomarkers were available in 738 participants [16] 
and full data on diet and FMD were available in 643 partic-
ipants [15]. The local ethics committee approved the study 
and all participants gave their written informed consent.
Dietary intake
Diet was assessed by a validated self-administered food fre-
quency questionnaire (FFQ) originally developed for Dutch 
participants of the EPIC study [17–19]. The FFQ queried 
participants to report habitual diet over the previous year. 
Energy and ethanol intake were calculated with the help of 
the extended Dutch food composition database from 1996. 
We assessed fruit (g/d), vegetables (g/d), fish (g/d) and 
dairy product (g/d) consumption, which were categorized 
into tertiles, and alcohol (g/d) consumption, which was 
categorized as follows: nonconsumers (no consumption of 
alcohol-containing beverages); moderate consumers (men: 
ethanol intake >0 and ≤20 g/d; women: ethanol intake >0 
and ≤10  g/d) and high consumers (men: ethanol intake 
>20 g/d; women: ethanol intake >10 g/d).
Red wine was dichotomized into nonconsumers (no 
consumption of red wine) and consumers (red wine con-
sumption; median (IQR) 28.6 (5.5–71.4) dL/d) and associa-
tions for alcohol and red wine were, additionally, mutually 
adjusted for each other.
Biomarkers of endothelial dysfunction and low-grade 
inflammation
Biomarkers were quantified in serum samples by a multi-
array detection system based on electrochemiluminescence 
technology (SECTOR Imager 2400, Meso Scale Discovery, 
Gaithersburg, MD, USA). sICAM-1, sVCAM-1, sE-selec-
tin and sTM were determined as biomarkers of endothe-
lial dysfunction, and CRP, SAA, IL-6, IL-8, TNF-α and 
sICAM-1 were determined as biomarkers of low-grade 
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inflammation. All serum samples were measured on a sin-
gle production lot of multi-array plates and in duplication 
on separate designated wells on the same array plate. Intra- 
and inter-assay CV were for sICAM-1, 2.4 and 4.9%; for 
sVCAM-1, 2.8 and 5.6%; for sE-selectin, 2.6 and 6.7%; for 
sTM, 2.1 and 6.9%; for CRP, 2.8 and 4.0%; for SAA, 2.7 
and 11.6%; for IL-6, 5.6 and 13.0%; for IL-8, 5.6 and 12.2% 
and for TNF-α, 3.9 and 8.8%, respectively. In addition, von 
Willebrand factor (vWf), a biomarker of endothelial dys-
function, was determined in citrated plasma by means of 
ELISA as described elsewhere [16]. Intra- and inter-assay 
CV were for vWf, 3.4 and 7.9%, respectively.
Flow-mediated vasodilation
FMD was measured in accordance with international 
guidelines [20, 21]. This method allows for the determina-
tion of the peak arterial vasodilatory response (maximum 
diameter) after cuff release [15], which reflects endothe-
lium-dependent vasodilation [22]. Briefly, baseline diam-
eter (mean of three measurements) was assessed with the 
use of an ultrasound scanner equipped with a 7.5 MHz lin-
ear probe (350 series, Pie Medical, Maastricht, The Nether-
lands) that was connected to a PC equipped with vessel wall 
movement detection software and an acquisition system 
(Wall Track System, Pie Medical, Maastricht, The Neth-
erlands). Baseline peak flow velocity (mean of two meas-
urements) was determined by pulsed-wave Doppler from a 
sample volume in the centre of the artery at a 60° angle. 
A pressure cuff, placed on the forearm, was then automati-
cally inflated and kept constant at supra-systolic pressure 
(SBP) (brachial SBP + 100 mmHg) in order to induce fore-
arm ischaemia. After 5 min, the cuff was released leading 
to an increase in blood flow and hereby in shear stress, 
which served as the stimulus for FMD response. Maxi-
mum peak flow velocity was measured within 15 s after the 
cuff release, and measures of arterial diameter were subse-
quently measured at 45, 90, 180 and 300 s.
In some individuals, measures of brachial diameter were 
missing at one (n = 70), two (n = 21) or three (n = 10) out of 
the four post-cuff release time points. For these individu-
als, we imputed the missing post-cuff release diameter(s) 
with a longitudinal regression method [23]. Specifically, 
we regressed the repeated post-cuff release measures of 
diameter available on baseline diameter and time with the 
use of generalized estimating equations. Because the rela-
tionship between time and diameter is not linear, time was 
treated as a categorical (dummy) variable to approximate 
the FMD response curve by estimation of the predicted 
diameter at each exact time point (i.e. at 45, 90,180 or 300 s 
after cuff release) based on the observed baseline and post-
cuff release measures obtained [24]. The predicted values 
hereby estimated were used to replace the missing value(s). 
FMD (peak arterial vasodilatory response, i.e. change 
in mm) was then calculated as maximum post-occlusion 
diameter minus baseline diameter and was used in the anal-
yses as main dependent variable.
Other variables
Health status, medical history, glucose metabolism status, 
medication use, educational level, physical activity and 
smoking habits were assessed by questionnaire. Height, 
weight, serum creatinine, albuminuria, total and HDL cho-
lesterol, blood pressure, BMI (kg/m2) and prior CVD were 
determined as described elsewhere [14–16]. Educational 
level was classified into six categories: primary education 
only; low level of secondary education; high level of sec-
ondary education; and tertiary education, either a bach-
elor degree, master degree or PhD. Physical activity was 
expressed in metabolic equivalents (METs) (hour/wk), 
based on the amount of daily activities, including sports, 
bicycling, gardening, walking, doing odd jobs and house-
keeping. Smoking behaviour was dichotomized into current 
smokers (15.1%) and nonsmokers, which included both 
previous smokers (45.5%) and never smokers (39.4%). Esti-
mated glomerular filtration rate (eGFR) (mL/min/1.73 m2) 
was calculated according to Levey’s [Chronic Kidney Dis-
ease Epidemiology Collaboration] formula [25].
Statistical analyses
Data analyses were performed with SPSS (Statistical Pack-
age for Social Sciences, version 20, IBM Corp., USA). 
Data were presented as mean (± SD), as median (interquar-
tile range) for skewed variables or as percentages and as 
regression coefficients (β) with their 95% confidence inter-
vals (95% CI). Variables with a skewed distribution were 
natural log-transformed in order to meet normality criteria 
(serum triglycerides, METs, CRP, SAA, IL-6 and IL-8).
Endothelial dysfunction
For reasons of statistical efficiency and to reduce the influ-
ence of the biological variability of each measure, a bio-
marker score for endothelial dysfunction was constructed 
using Z-scores as previously described elsewhere [16, 
26–28]. The endothelial dysfunction biomarker score con-
sisted of vWf, sE-selectin, sTM, sVCAM-1 and sICAM-1, 
with a higher score indicating worse function.
With regard to FMD, the peak arterial vasodilatory 
response (i.e. the change (in mm)) was used as outcome 
variable (lower FMD indicating worse function).
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Low‑grade inflammation
The low-grade inflammation biomarker score consisted of 
CRP, SAA, IL-6, IL-8, TNF-α and sICAM-1 (sICAM-1 
was included in both biomarker scores as it is expressed by 
both monocytes and the endothelium) [16, 26–28], with a 
higher score indicating more inflammation.
Statistical models
Firstly, we used linear regression analyses to investigate the 
cross-sectional associations between, on the one hand, ter-
tiles of fruit, vegetables, fish and dairy product consump-
tion and categories of alcohol consumption and, on the 
other hand, the endothelial dysfunction biomarker score 
and FMD. Secondly, we investigated the cross-sectional 
associations between the above food groups and the low-
grade inflammation biomarker score. These analyses were 
adjusted for sex, age, glucose metabolism status and energy 
intake. For FMD, the analyses were additionally adjusted 
for baseline diameter and flow increase (models 1). These 
associations were then additionally adjusted for BMI, cur-
rent smoking, prior CVD, educational level and physical 
activity (models 2), and for each of the other food com-
ponents of a healthy diet (i.e. fruit, vegetables, fish, dairy 
products and/or alcohol) (models 3). Thirdly, we repeated 
the above analyses for red wine consumption (models 
1 to 3). Next, the associations for alcohol (i.e. ethanol) 
and red wine consumption were mutually adjusted for 
each other. Finally, the presence of clinical disease may 
modify any effect of diet on CVD [28, 29]. In particular, 
it has been suggested that the consumption of red wine 
may be favourable in CVD [13], whereas the consump-
tion of dairy products may have adverse effects [30]. We 
used interaction terms between clinical disease and food 
consumption to investigate any such effects. In the present 
study, clinical disease was defined as the presence of either 
CVD (n = 242), type 2 diabetes mellitus (n = 137) or both 
(n = 184).
A two-sided P-value < 0.05 and for interaction < 0.10 
was considered statistically significant.
Results
The results section focuses on the independent associations 
between diet and endothelial dysfunction and low-grade 
inflammation (i.e. here alcohol and red wine consumption 
only). Nevertheless, we systematically report results on 
each of the food groups in the supplemental material and 
tables.
Study population
Ninety-one percent (n = 729) of the 801 participants were 
>60 (range 50–87) years of age. With regard to the con-
sumption of alcohol, 139 individuals were classified as 
nonconsumers (34 men and 105 women: no consumption 
of alcohol-containing beverages at all), 414 were classified 
as moderate consumers (237 men: ethanol intake >0 and 
≤ 0 g/d; 177 women: ethanol intake >0 and ≤10 g/d), and 
248 were classified as high consumers (131 men: ethanol 
intake >20 g/d; 117 women: ethanol intake >10 g/d).
Age, the ratio of women to men, the prevalence of type 
2 diabetes mellitus, a low-educational level and the use 
of anti-hypertensive medication decreased over the cat-
egories of alcohol consumption. In contrast, current smok-
ing, physical activity, estimated glomerular filtration rate 
(eGFR) and HDL cholesterol, and the intake of energy, red 
wine, vegetables and fish increased over the categories of 
alcohol consumption (Table 1).
As compared to the participants with full data, those 
without either biomarker (n = 63) or FMD (n = 158) data 
had a higher BMI and lower educational level, and used 
anti-hypertensive medication more frequently (P-val-
ues <0.05). In addition, those without biomarker data were 
younger and had type 2 diabetes mellitus more frequently, 
whereas those without FMD data were older and less phys-
ically active, had a lower eGFR and consumed alcohol and 
red wine less frequently (P-values <0.05, other data not 
shown). The presence of clinical disease in participants 
with data was 70%.
Alcohol consumption and endothelial dysfunction
After adjustment for sex, age, glucose metabolism sta-
tus and energy intake, moderate and high consumers had 
a lower endothelial dysfunction biomarker score [β (95% 
CI) −0.16 (−0.37; 0.04) and −0.23 (−0.45; −0.01), respec-
tively (Table  2, model 1)] as compared to nonconsumers 
(reference group; P-trend = 0.051). The results showed a 
positive association for FMD that was not statistically sig-
nificant [0.01 (−0.21; 0.23) and 0.16 (−0.08; 0.39), respec-
tively (Table 2, model 1)]. Additional adjustment for BMI, 
current smoking, prior CVD, educational level, physical 
activity and each of the other food components of a healthy 
diet did not materially change the results (Table 2, models 
2–3).
Red wine consumption and endothelial dysfunction
After adjustment for sex, age, glucose metabolism status 
and energy intake, red wine consumers [n = 365; median 
(IQR) intake, 28.6 (5.5–71.4) dL/d] had a lower endothe-
lial dysfunction biomarker score [0.21 (−0.35; −0.07), 
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Table 1  Population characteristics, diet, endothelial dysfunction and low-grade inflammation according to categories of alcohol consumption
Categories of alcohol consumption P-trend
None Moderate High
Population characteristics
 Age, year 70.7 ± 7.1 68.8 ± 7.2 66.8 ± 6.9 <0.001
 Sex, Men/Women 34/105 237/177 131/117 <0.001
 Glucose metabolism status*
 Normal glucose metabolism, % 23.9 40.4 36.9
 Impaired glucose metabolism, % 18.1 23.8 24.1
 Diabetes mellitus type 2, % 58.0 35.8 39.0 0.006
 Body mass index, kg/m2 28.1 ± 5.0 27.5 ± 4.1 27.8 ± 3.8 0.591
 Current smoking, % 12.9 13.3 19.4 0.048
 Prior cardiovascular disease, % 62.8 52.2 52.7 0.105
 Low-educational level, % 41.3 26.5 19.8 <0.001
 Physical activity, METs hour/week 49 [21–99] 81 [47–129] 85 [51–132] <0.001
 Systolic blood pressure, mmHg 142 ± 22 142 ± 20 142 ± 20 0.651
 Diastolic blood pressure, mmHg 83 ± 11 83 ± 11 84 ± 11 0.378
 Anti-hypertensive medication, % 51.8 37.0 35.9 0.006
 Total cholesterol, mmol/L 5.7 ± 1.1 5.6 ± 1.1 5.9 ± 0.9 0.051
 HDL cholesterol, mmol/L 1.3 ± 0.4 1.3 ± 0.4 1.5 ± 0.4 <0.001
 LDL cholesterol, mmol/L 3.6 ± 1.0 3.6 ± 0.9 3.6 ± 0.8 0.585
 Triglycerides, mmol/L 1.5 [1.1–2.2] 1.3 [1.0–1.8] 1.3 [1.0–2.0] 0.838
 Lipid-lowering medication, % 18.0 15.9 17.7 0.931
 Albuminuria [albumin/creatinine ratio > 2 (mg/mmol)], % 15.1 16.3 13.8 0.624
 Serum creatinine, µmol/L 91.6 ± 17.1 96.4 ± 17.7 95.6 ± 16.1 0.083
 eGFR, mL/min/1.73 m2 60.9 ± 12.4 63.5 ± 11.2 64.2 ± 11.1 0.014
Diet
 Energy intake, kJ/d 7063 ± 2323 8032 ± 2065 9070 ± 3709 <0.001
 Ethanol, g/d 0.0 [0.0–0.0] 3.5 [1.0-8.1] 28.7 [20.1–40.0] By definition
 Red wine, dL/d 0.0 [0.0–0.0] 0.0 [0.0–14.3] 12.1 [0.0–85.7] <0.001
 Vegetables, g/d 121 ± 50 125 ± 49 136 ± 61 0.005
 Fruit, g/d 302 ± 177 288 ± 168 271 ± 164 0.068
 Fish, g/d 4.4 [0.0-14.9] 8.8 [2.8–16.8] 13.2 [4.3–18.0] <0.001
 Dairy products, g/d 450 ± 311 470 ± 270 413 ± 210 0.072
Endothelial dysfunction
 Endothelial dysfunction score, SD 0.15 ± 0.66 0.002 ± 0.66 −0.08 ± 0.59 0.002
 von Willebrand factor, % 167 ± 53 155 ± 60 148 ± 46 0.002
 Soluble endothelial selectin, µg/L 20 ± 9 19 ± 8 20 ± 8 0.426
 Soluble thrombomodulin, µg/L 3.6 ± 1.0 3.6 ± 0.9 3.4 ± 0.9 0.012
 Soluble vascular cell adhesion molecule 1, µg/L 437 ± 102 417 ± 103 398 ± 87 <0.001
 Soluble intercellular adhesion molecule 1, µg/L 275 ± 68 261 ± 64 261 ± 62 0.115
 Flow-mediated vasodilation
 Baseline diameter, mm 4.46 ± 0.75 4.71 ± 0.73 4.72 ± 0.76 0.014
 Peak diameter after cuff release, mm 4.60 ± 0.75 4.87 ± 0.71 4.92 ± .0.75 0.001
 Peak diameter change after cuff release, mm 0.14 ± 0.11 0.16 ± 0.17 0.20 ± 0.18 0.001
Low-grade inflammation
 Low-grade inflammation score, SD 0.13 ± 0.61 -0.02 ± 0.61 −0.03 ± 0.65 0.051
 C-reactive protein, mg/L 3.1 [1.5–5.9] 2.3 [1.2–4.9] 2.4 [1.1–4.3] 0.040
 Serum amyloid A, mg/L 2.6 [1.3–3.5] 1.7 [1.0–3.2] 1.7 [1.0–3.2] 0.027
 Interleukin-6, ng/L 1.7 [1.1–2.5] 1.5 [1.1–2.2] 1.4 [1.0–2.4] 0.597
 Interleukin-8, ng/L 15.5 [11.8–20.4] 11.0 [14.0–18.1] 13.9 [10.9–19.3] 0.953
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(Table  2, model 1)] as compared to nonconsumers of red 
wine (reference group). The results showed a positive asso-
ciation for FMD that was not statistically significant [0.08 
(−0.07; 0.23), (Table 2, model 1)]. Additional adjustment 
for BMI, current smoking, prior CVD, educational level, 
physical activity and each of the other food components of 
a healthy diet did not materially change the results (Table 2, 
models 2–3).
Mutual adjustment
The association between alcohol consumption and the 
endothelial dysfunction biomarker score (Table  2, model 
2) was attenuated after additional adjustment for red wine 
consumption (Table 2, model 4a). The association between 
red wine consumption and the endothelial dysfunction bio-
marker score (Table 2, model 2) did not materially change 
after additional adjustment for ethanol (Table 2, model 4b).
Alcohol consumption, red wine consumption 
and low-grade inflammation
The consumption of alcohol was not associated with the 
low-grade inflammation biomarker score. After adjust-
ment for sex, age, glucose metabolism status and energy 
intake, red wine consumers had a lower low-grade inflam-
mation biomarker score [−0.23 (−0.37; −0.09), (Table 2, 
model 1)] as compared to nonconsumers of red wine (ref-
erence group). Additional adjustment for BMI, current 
smoking, prior CVD, educational level, physical activity 
and each of the other food components of a healthy diet 
did not materially change the results (Table  2, models 
2–3). The association between red wine consumption and 
the low-grade inflammation biomarker score (Table  2, 
model 2) did not materially change after additional 
adjustment for ethanol (Table 2, model 4b).
Other food groups and endothelial dysfunction 
and low-grade inflammation
Vegetable, fruit, fish and dairy product consumption 
were neither associated with endothelial dysfunction 
(Supplemental Table 1) nor with low-grade inflammation 
(Supplemental Table 1).
Results according to the presence or absence of clinical 
disease
The consumption of red wine was inversely associated 
with the low-grade inflammation circulation biomarker 
score in participants with clinical disease (Supplemen-
tal Table  2; P-interaction: 0.09). In addition, the results 
for dairy products showed that the consumption of dairy 
products was inversely associated with the endothelial 
dysfunction biomarker score in participants with clinical 
disease (Supplemental Table 2: P-interaction: 0.07).
As the latter result appeared in contrast to our hypoth-
esis, we repeated stratified analyses for the follow-
ing components of total dairy products: cheese, low 
(<2.0%)- and high (≥2.0%)-fat dairy products. Although 
not statistically significant, the results showed an inverse 
association for low-fat dairy production consumption in 
participants with clinical disease as opposed to a posi-
tive association for high-fat dairy products in participants 
without clinical disease (Supplemental Table 2).
Table 1  (continued)
Categories of alcohol consumption P-trend
None Moderate High
 Tumour necrosis factor α, ng/L 9.2 ± 2.5 8.8 ± 3.0 8.8 ± 3.1 0.361
 Soluble intercellular adhesion molecule 1, µg/L 275 ± 68 261 ± 64 261 ± 62 0.115
Data are means ± SD, median [interquartile range] or percentages, as appropriate, according to the following categories of alcohol consumption: 
nonconsumers (n = 139); moderate consumers (men: ethanol intake 0–20 g/d; women: ethanol intake 0–10 g/d; n = 414); and high consumers 
(men: ethanol intake > 20 g/d; women: ethanol intake > 10 g/d; n = 248); P-trend by linear regression analysis for continuous variables and by 
Chi-square test for proportions
METs metabolic equivalents; HDL high-density lipoprotein; LDL low-density lipoprotein; eGFR estimated glomerular filtration rate according to 
Levey’s [Chronic Kidney Disease Epidemiology Collaboration (CKD-epi)] formula for the following four strata (only Caucasians present in the 
Hoorn study population); (1) women, serum creatinine ≤ 62 µmol/L: eGFR = 144 × (serum creatinine/0.7)−0.329 × (0.993)Age ; (2) women, serum 
creatinine > 62 µmol/L: eGFR = 144 × (serum creatinine/0.7)−1.209 × (0.993)Age ; (3) men, serum creatinine ≤ 80 µmol/L: eGFR = 141 × (serum 
creatinine/0.9)−0.411 × (0.993)Age ; (4) men, serum creatinine > 80 µmol/L: eGFR = 141 × (serum creatinine/0.9)−1.209 × (0.993)Age [25]
*Normal glucose metabolism: fasting plasma glucose <6.1  mmol/L and 2-h post-load plasma glucose <7.8  mmol/L; impaired glucose 
metabolism: impaired fasting plasma glucose between 6.1 and 7.0 mmol/L and impaired glucose tolerance defined as a 2-h post-load plasma 
glucose between 7.8 and 11.1  mmol/L; diabetes mellitus type 2: fasting plasma glucose >7.0  mmol/L and/or 2-h post-load plasma glucose 
≥11.1 mmol/L
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Table 2  Associations between categories of alcohol and red wine consumption and endothelial dysfunction and low-grade inflammation
Data are standardized regression coefficients, with their 95% confidence intervals, indicating the difference in the endothelial dysfunction bio-
marker score, flow-mediated vasodilation (FMD) and the low-grade inflammation biomarker score (all in SD) between categories of alcohol 
consumption, with moderate (men: ethanol intake 0–20 g/d; women: ethanol intake 0–10 g/d) and high consumers (men: ethanol intake >20 g/d; 
women: ethanol intake >10 g/d) compared to nonconsumers (-, reference group); and between red wine consumers [median (IQR) 28.6 (5.5–
71.4) dL/d] and nonconsumers (-, reference group), with P-values and P-trend by linear regression analyses
Analyses on biomarker scores include 738 participants and higher values indicate worse function
Analyses on FMD include 643 participants and lower values indicate worse function; to calculate peak diameter change in millimetres multiply 
by 0.167 (SD)
Model 1: adjusted for sex, age, glucose metabolism status, energy intake and for FMD additionally for baseline diameter and flow increase
Model 2: model 1 additionally adjusted for body mass index, current smoking, prior cardiovascular disease, educational level and physical activ-
ity
Model 3: model 2 additionally adjusted for vegetable, fruit, fish and dairy product consumption
Model 4a: model 2 additionally adjusted for red wine (dL/d)
Model 4b: model 2 additionally adjusted for alcohol (g/d)
Model Endothelial dysfunction Low-grade inflammation
Biomarker score Flow-mediated vasodilation Biomarker score
β (95% CI) P-value P-trend β (95% CI) P-value P-trend β (95% CI) P-value P-trend
Alcohol
 1
  None – – –
  Moderate −0.16 (−0.37; 0.04) 0.116 0.01 (−0.21; 0.23) 0.952 −0.12 (−0.32; 0.09) 0.275
  High 0.23 (−0.45;-0.01) 0.040 0.051 0.16 (−0.08; 0.39) 0.200 0.114 −0.07 (−0.30; 0.16) 0.539 0.717
 2
  None – – –
  Moderate −0.13 (−0.33; 0.07) 0.204 −0.02 (−0.24; 0.20) 0.843 −0.08 (−0.28; 0.13) 0.455
  High −0.23 (−0.45; −0.01) 0.040 0.038 0.17 (−0.06; 0.41) 0.150 0.061 −0.07 (−0.30; 0.15) 0.515 0.594
 3
  None – – –
  Moderate −0.13 (−0.33; 0.07) 0.212 −0.03 (−0.25; 0.19) 0.796 −0.08 (−0.28; 0.13) 0.455
  High −0.22 (−0.45; −0.003) 0.047 0.047 0.17 (−0.07; 0.41) 0.163 0.073 −0.06 (−0.29; 0.16) 0.574 0.663
 4a
  None –
  Moderate −0.12 (−0.33; 0.08) 0.226
  High −0.18 (−0.41; 0.05) 0.122 0.137
Red wine
 1
  Nonconsumers – – –
  Consumers −0.21 (−0.35; −0.07) 0.004 0.08 (−0.07; 0.23) 0.291 −0.23 (−0.37; −0.09) 0.002
 2
  Nonconsumers – – –
Consumers −0.16 (−0.31; −0.02) 0.028 0.07 (−0.08; 0.23) 0.361 −0.19 (−0.34; −0.04) 0.013
 3
  Nonconsumers – – –
  Consumers −0.16 (−0.30; −0.01) 0.034 0.07 (−0.09; 0.22) 0.414 −0.18 (−0.33; −0.04) 0.016
 4b
  Nonconsumers – –
  Consumers −0.15 (−0.30; −0.003) 0.045 −0.19 (−0.34; −0.04) 0.012
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Additional analyses
Results for individual biomarkers (Fig.  1), other potential 
confounders, alternative categorization of alcohol and red 
wine consumption, other types of alcoholic beverages and 
accounting for missing data have been addressed in the 
online supplement.
Discussion
The present study builds on previous reports, which 
focused on diet scores or single food components [3–8], 
by investigation of each of the independent associations 
between fruit, vegetables, fish, dairy products, alcohol and 
red wine consumption and endothelial dysfunction (deter-
mined by a set of five plasma biomarkers and FMD), in 
addition to low-grade inflammation (determined by a set 
of six plasma biomarkers), within one population-based 
cohort. The study had two main findings. Firstly, after 
adjustment for potential confounders, both alcohol and red 
wine consumption were associated with a lower endothelial 
dysfunction biomarker score and a greater FMD. The asso-
ciations for FMD were, however, not statistically signifi-
cant. Importantly, these results were independent of each 
of the other food components of a healthy diet. Secondly, 
after adjustment for potential confounders, none of the food 
groups showed an association with the low-grade inflam-
mation biomarker score, except for the consumption of red 
wine. Red wine consumption was associated with a lower 
low-grade inflammation biomarker score. This association 
was independent of each of the other food components of a 
healthy diet and was strongest in participants with clinical 
disease.
Healthy dietary components may improve endothe-
lial dysfunction and low-grade inflammation through sev-
eral potential mechanisms, such as inhibition of intracel-
lular signalling pathways that activate the inflammatory 
response, reduction of oxidative stress, modulation of cell 
membrane stability, modulation of endothelial nitric oxide 
synthase activity, modulation of the eicosanoid pathway 
by alteration of prostaglandin synthesis and modulation 
of endothelial-derived hyperpolarizing factor, which may 
influence vascular smooth muscle cell tone [13, 31–33]. 
The present results expand previous knowledge on the asso-
ciations between diet and endothelial dysfunction and low-
grade inflammation [3–11] as it showed that in particular 
alcohol-containing beverage consumption (i.e. alcohol and 
red wine) was independently associated with less endothe-
lial dysfunction and less low-grade inflammation. In addi-
tion, the observation that the association for red wine and 
low-grade inflammation was stronger in participants with 
diabetes and CVD may shed some new light upon the 
dietary recommendations with regard to the consumption 
of alcohol and red wine in these patients [29].
The vascular endothelium has many functions in a heter-
ogeneous way throughout the vasculature [22]. The exten-
sive array of endothelium-derived biomarkers and FMD (a 
measure of endothelium-dependent vasodilation) capture 
several dimensions of endothelial dysfunction [22]. Indeed, 
both higher concentrations of the biomarkers and a smaller 
FMD response are associated with (incident) CVD [34, 35]. 
The present results for alcohol and red wine showed that, in 
particular, high alcohol consumers and red wine consum-
ers had a lower endothelial dysfunction biomarker score 
and greater FMD, which have been associated with less 
CVD. The results for FMD were, however, not statistically 
significant. This might be explained by the fact that 158 
participants missed FMD data due to a greater body mass 
index [15], which by itself is associated with a less healthy 
diet [36] and a smaller FMD response [15]. Addition-
ally, the fact that associations for FMD were investigated 
in 643 individuals versus 738 individuals for biomarker 
scores may have led to underestimation of the associations 
for FMD as compared to those of biomarker scores. Alter-
natively, the results suggest differential effects of dietary 
compounds on individual dimensions of endothelial dys-
function, as suggested by previous studies [6, 10, 13].
Additionally, it is unclear to what extent alcohol itself 
(i.e. ethanol) or any additional nutrient components such as 
polyphenols and flavonoids may determine the association 
between alcohol and endothelial dysfunction and low-grade 
inflammation [13]. In the present study, the association 
between alcohol consumption and the endothelial dys-
function biomarker score was attenuated after adjustment 
for red wine, while the associations between red wine and 
the endothelial dysfunction and low-grade inflammation 
biomarker scores did not materially change after adjust-
ment for alcohol consumption. This suggests that red wine 
itself, rich in polyphenols and flavonoids, determines its 
association with lower adhesion molecules and inflamma-
tory mediators (i.e. biomarkers) independent of its alcohol 
content [12], while an association between alcohol and 
biomarkers that is independent from red wine cannot be 
excluded.
A role for the other food components of a healthy diet on 
endothelial dysfunction and low-grade inflammation was 
less clear. In particular, we hypothesized that lower total 
dairy product consumption was favourably associated with 
low-grade inflammation. However, the result for total dairy 
product consumption in participants with clinical disease 
appeared to oppose our hypothesis and we cannot fully rule 
out the play of chance. Nevertheless, additional analyses 
with components of total dairy products showed that more 
low-fat dairy product consumption was associated with 
lower biomarkers of endothelial dysfunction in diabetes 
Eur J Nutr 
1 3
and CVD, whereas more high-fat dairy product consump-
tion was associated with higher biomarkers of endothelial 
dysfunction in participants free of clinical disease. This 
observation might explain how high-fat, but not low-fat, 
dairy product consumption was associated with CVD mor-
tality [17, 30]. It is however important to realize that these 
results, despite their association as given by the regression 
coefficients, were not statistically significant and should be 
interpreted with caution.
Limitations of the study may have affected our results. 
Firstly, although we hypothesized that more vegetable, 
fruit and fish consumption were favourably associated 
with endothelial dysfunction and low-grade inflammation 
[1], we cannot exclude that the variation in consumption 
between persons was too small to reveal any associations 
between these food groups and endothelial dysfunction and 
low-grade inflammation. Alternatively, effects of (any of) 
these food groups might primarily be seen earlier in life 
[27]. Thirdly, it is likely that participants with an unhealthy 
diet, worse endothelial dysfunction and worse low-grade 
inflammation have died before the start of the study causing 
a survival bias that could have led to an underestimation of 
the reported associations [1]. Furthermore, any inferences 
towards causality should be interpreted with caution as the 
data are cross-sectional. Finally, intrinsic to an overall bio-
marker score is the assumption that each biomarker in the 
score carries similar weight. Consequently, this approach 
may not optimally reflect pathophysiology as it is unknown 
if the relationship between food intake and circulating bio-
markers as a proxy for cardiovascular disease is similar for 
each circulating biomarker.
In conclusion, alcohol and red wine consumption were 
associated with lower biomarkers of endothelial dysfunc-
tion and red wine consumption was associated with lower 
biomarkers of low-grade inflammation, whereas results for 
vegetable, fruit, fish and dairy product consumption were 
less clear. Importantly, these results were independent of 
vegetable, fruit, fish and dairy product consumption. This 
suggests that food components of a healthy diet, and in 
particular alcohol-containing beverage consumption, may 
favourably influence endothelial dysfunction and low-grade 
inflammation.
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Fig. 1  Endothelial dysfunction biomarkers (a) and low-grade inflam-
mation biomarkers (b) for red wine consumers, compared to non-
consumers. Dots show scores and individual biomarker associations 
adjusted conform models 2, with whiskers indicating their 95% confi-
dence intervals. Higher biomarkers indicate worse function and more 
inflammation. ED endothelial dysfunction biomarker score; vWf von 
Willebrand factor; sICAM‑1 soluble intercellular adhesion molecule 
1; sVCAM‑1 soluble vascular cell adhesion molecule 1; sTM soluble 
thrombomodulin; sE‑selectin soluble endothelial selection; LGI low-
grade inflammation biomarker score; TNF‑a tumour necrosis factor 
alpha; ln natural log normalized; CRP C-reactive protein; IL‑6 inter-
leukin-6; SAA serum amyloid A; IL‑8 interleukin 8
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